AlphaLens

TERMINAL

ANALYSIS

Heatmap Stock Lists AlphaBrain Compare Track Record News Rumor Radar Calendar Macro Leaderboard ETF X-Ray Learn

MY SPACE

Dashboard Watchlist Portfolio Achievements Settings

QUICK ACCESS

AAPLApple MSFTMicrosoft NVDANVIDIA GOOGLAlphabet AMZNAmazon TSLATesla

Home Screener Watchlist Account

v12

TICKER Dashboard Screener Macro

UTC ●

LOADING MARKET DATA… │ UTC ●

Loading page…

Screener·Stocks·Lists·Heatmap·Top Picks·Deep-Dives·AlphaBrain·Track Record·Accountability·News·Rumor Radar·Compare·Learn·Free SEC Filings·Pricing·FAQ·Terms·Privacy

AlphaLens provides algorithmic financial data and pre-computed AI analysis for educational and informational purposes only. AlphaScore™, TSI™, EQS™, AlphaMomentum™, Close-vs-Gap Pressure, CER™, Volatility Regime™, Earnings Execution™, Macro Regime Detector™, Portfolio Health Engine™, and Similarity Engine™ are proprietary mathematical algorithms. No output constitutes investment advice or a guarantee of future performance. Conduct independent research. Consult a licensed financial advisor.

DaVita Inc. (DVA)

DaVita Inc.

Healthcare

$179.25

+1.26%

nightly snapshot · 10/11/2026

ALPHASCORE™ · C · Neutral

ALPHASCORE

/ 100

NEUTRAL

▲ 0 · 30D

KEY FUNDAMENTALS

P/E15.1

ROE-114.7%

NET MARGIN5.5%

GROSS MARGIN32.4%

MKT CAP$11.51B

loading full analysis…

DAILY BRIEF

DaVita Inc. (Healthcare sector) displays an AlphaScore of 47/100 with a neutral signal as of 2026-10-11. Key fundamentals include a net margin of 5.47% and a very high debt-to-equity ratio of 12.42. A notable strength is its high value subscore of 83, while a major risk is its severely negative ROE of -114.70%.

Written 11/10/2026, 00:40:41 UTC · Snapshot 11/10/2026